Comments
Loading...
Lombard Medical Analyst Ratings and Price Targets | OTC:EVARF | Benzinga
Lombard Medical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Lombard Medical Corp from these most-recent analyst ratings.
Analyst Ratings for Lombard Medical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Lombard Medical (EVARF) stock?
There is no price target for Lombard Medical
What is the most recent analyst rating for Lombard Medical (EVARF)?
There is no analyst for Lombard Medical
When was the last upgrade for Lombard Medical (EVARF)?
There is no last upgrade for Lombard Medical
When was the last downgrade for Lombard Medical (EVARF)?
There is no last downgrade for Lombard Medical.
When is the next analyst rating going to be posted or updated for Lombard Medical (EVARF)?
There is no next analyst rating for Lombard Medical.
Is the Analyst Rating Lombard Medical (EVARF) correct?
There is no next analyst rating for Lombard Medical.
Browse analyst ratings and price targets on all stocks.
